Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Risk: Retrospective Study of 50 Type 2 Diabetic Patients with Chronic Heart Failure
Narcissse Ateba Assene, Patrick Hassler, Cecile Deharvengt, Ahmadou Musa Jingi, Monique Gladin & Emmanuel Andrès · Journal of Advances in Medicine and Medical Research · 2017
Objectives: The choice of antidiabetics in patients with heart failure is a major clinical concern. Some antidiabetic agents such as thiazolidinediones, more or less sulfonamides and insulin increase the risk of exacerbation of heart failure. There is controversy with regard to t...
Open access
Research Article
10.9734/BJMMR/2017/22039